Elevation Oncology (NASDAQ:ELEV) Earns Equal Weight Rating from Stephens
Elevation Oncology (NASDAQ:ELEV – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by research analysts at Stephens in a report issued on Monday, Marketbeat Ratings reports. They presently have a $1.00 target price on the stock, down from their prior target price of $5.00. Stephens’ price target would indicate a potential upside of […]
Elevation Oncology (NASDAQ:ELEV – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by research analysts at Stephens in a report issued on Monday, Marketbeat Ratings reports. They presently have a $1.00 target price on the stock, down from their prior target price of $5.00. Stephens’ price target would indicate a potential upside of […]
